Health
Study shows vaccine’s potential to stop viral spread – The Australian Financial Review
The news is potentially good for Australia as the Oxford-AstraZeneca vaccine is being manufactured onshore by CSL.
The study design focused on the interval between the two jabs and how this affected the level of protection against becoming ill with COVID-19.
But it covered transmission too, as the Oxford University newsletter explains:
The authors also report further on the potential for the vaccine to reduce transmission of the virus, based on swabs obtained from volunteers in the UK arms of the trial with a 67 per cent reduction after the first dose of the vaccine.
But they say the data is preliminary and…
-
Noosa News18 hours agoIncrease in extreme weather events poses ‘substantial risk’ to blood supplies, researchers warn
-
General22 hours agoGerman palliative care doctor with alleged ‘lust for murder’ accused of killing 15 patients
-
Noosa News8 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate
-
Noosa News13 hours agoManjimup engineer turns previously wasted avocados into liquid gold